HIV-1 neutralizing antibodies induced by native-like envelope trimers
Rogier W. Sanders(Scripps Research Institute), John P. Moore(Cornell University), Eva G. Rakasz(University of Wisconsin–Madison), David C. Montefiori(Duke University), Gargi Debnath(Cornell University), Ian A. Wilson(Raigmore Hospital), Marit J. van Gils(Amsterdam University Medical Centers), Thomas J. Ketas(Cornell University), Jeong Hyun Lee(Scripps Research Institute), Miklós Guttman(University of Washington), Leslie Goo(San Mateo County Community College District), Brian Moldt(Altimmune (United States)), Judith A. Burger(Amsterdam University Medical Centers), Hansi Dean(Takeda (United States)), Cassandra A. Simonich(Seattle Children's Hospital), Pavel Pugach(Cornell University), Albert Cupo(Cornell University), Gabriel Ozorowski(Scripps Research Institute), Devin Sok(Scripps Research Institute), Helen J. Kim(Scripps Research Institute), Per Johan Klasse(Cornell University), Kelly K. Lee(University of Washington), Ronald Derking(Amsterdam UMC Location University of Amsterdam), Jean‐Philippe Julien(University of Toronto), Mariëlle J. van Breemen(Amsterdam UMC Location University of Amsterdam), Celia C. LaBranche(Duke University), Dennis R. Burton(Scripps Research Institute), Gözde Isik(Amsterdam UMC Location University of Amsterdam), William R. Schief(Scripps Research Institute), Andrew B. Ward(Scripps Research Institute), Jaap Willem Back(University of Amsterdam), Julie Overbaugh(Gold Coast Hospital), Max Medina-Ramírez(Amsterdam UMC Location University of Amsterdam), Michael S. Seaman(Beth Israel Deaconess Medical Center), Heather Arendt(International AIDS Vaccine Initiative), Melissa Williams(Cornell University), Wayne C. Koff(Human Immunome Project)
Cited by 529
Related Papers
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k